GolinHarris lands Omega Pharma portfolio from Virgo

Omega Pharma has moved its entire portfolio into the new healthcare practice at GolinHarris, following the agency's acquisition of Virgo Healthcare last year.

Nytol: Part of the Omega Pharma porfolio
Nytol: Part of the Omega Pharma porfolio

The pharma company has moved its business out of Virgo and into GolinHarris’ healthcare practice, which opened for business last week. Sian Boisseau, former director of consumer health at Virgo, leads the account.

GolinHarris’ new healthcare team of five is charged with raising awareness of Omega Pharma’s over-the-counter brands, targeting both consumer and trade media, as the company looks to become one of the top three in its sector within five years. 

Omega Pharma’s portfolio includes sleeping aid brand Nytol, pain relief brand Solpadeine, and mosquito repellent Jungle Formula.

While Virgo and GolinHarris’ healthcare practices sit alongside each other within parent company Interpublic Group, Virgo’s offices remain in Richmond. The Omega Pharma account has been moved out of the building to avoid conflicts of interest with Virgo’s other over-the-counter clients, such as Reckitt Benckiser.

Boisseau continues to report to Angie Wiles and Sarah Matthew, joint global healthcare practice leaders at GolinHarris and joint chief executives of Virgo Healthcare.

Wiles said the two agencies would be ‘collaborating where appropriate but [remain] separate where client conflicts exist’. ‘It is a natural but important progression for us to establish a healthcare team within GolinHarris London that can also deliver the uncompromised health comms for which Virgo has become known,’ she added.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.

Max Clifford trial jury reconvenes with majority verdicts direction

Max Clifford trial jury reconvenes with majority verdicts direction

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has reconvened after being told by the judge yesterday afternoon that he will now accept majority verdicts.